| Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
| [0060]
|
| Human Adipose-Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses
| [0060]
|
| J. Biomed. Mater. Res.
| [0077]
|
| J. Biomed. Mater. Res.
| [0077]
|
| J. Biomed. Mater. Res.
| [0077]
|
| Orthop. Res.
| [0077]
|
| Culture of Animal Cells: A Manual of Basic Technique
| [0097]
|
| Human Gene Therapy
| [0101]
|
| Calcif. Tissue Int.
| [0101]
|
| Nat. Med.
| [0103]
|
| Molecular Cloning A Laboratory Manual
| [0182]
|
| DNA Cloning
| [0182]
|
| Oligonucleotide Synthesis
| [0182]
|
| Nucleic Acid Hybridization
| [0182]
|
| Transcription And Translation
| [0182]
|
| Culture Of Animal Cells
| [0182]
|
| Immobilized Cells And Enzymes
| [0182]
|
| A Practical Guide To Molecular Cloning
| [0182]
|
| Methods In Enzymology
| [0182]
|
| Gene Transfer Vectors For Mammalian Cells
| [0182]
|
| Immunochemical Methods In Cell And Molecular Biology
| [0182]
|
| Handbook Of Experimental Immunology
| [0182]
|
| Manipulating the Mouse Embryo
| [0182]
|
| American Gastroenterological Association Medical Position Statement: Perianal Crohn's Disease
| [0183]
|
| Inflamm Bowel Dis
| [0183]
|
| Acta Gastroenterol Belg
| [0183]
|
| Eur J Surg
| [0183]
|
| Plastic Reconstr Surg
| [0183]
|
| Tissue Eng
| [0183]
|
| Int J Colorectal Dis
| [0183]
|
| New Engl J Med
| [0183]
|
| Lancet
| [0183]
|
| Nat Biotechnol.
| [0183]
|
| New Eng J Med
| [0183]
|
| Science
| [0183]
|
| Annu. Rev. Cell Dev. Biol.
| [0183]
|
| Science
| [0183]
|
| Curr Top Microbiol Immunol.
| [0183]
|
| Science
| [0183]
|
| Cells Tissues Organs
| [0183]
|
| Exp Hematol.
| [0183]
|
| Orthop Res.
| [0183]
|
| Science
| [0183]
|
| J Cell Sci.
| [0183]
|
| Clin Orthop.
| [0183]
|
| Muscle Nerve
| [0183]
|
| Bone.
| [0183]
|
| Exp Neurol.
| [0183]
|
| Am Surg.
| [0183]
|
| Exp Hematol
| [0183]
|
| Trends Mol Med.
| [0183]
|
| J Biol Chem
| [0183]
|
| Crohn's disease. Lancet
| [0184]
|
| The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
| [0184]
|
| The spectrum of perianal Crohn's disease in a population-based cohort
| [0184]
|
| Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease
| [0184]
|
| Pathophysiology of fistula formation in Crohn's disease
| [0184]
|
| Diagnosis and management of fistulizing Crohn's disease
| [0184]
|
| The clinical course of fistulating Crohn's disease
| [0184]
|
| Infliximab maintenance therapy for fistulizing Crohn's disease
| [0184]
|
| Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study
| [0184]
|
| Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study
| [0184]
|
| Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
| [0184]
|
| Infliximab for the treatment of fistulas in patients with Crohn's disease
| [0184]
|
| Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
| [0184]
|
| 6-Mercaptopurine is effective in Crohn's disease without concomitant steroids
| [0184]
|
| Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease
| [0184]
|
| Metronidazole therapy for perineal Crohn's disease: a follow-up study
| [0184]
|
| Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease
| [0184]
|
| Disappointing durable remission rates in complex Crohn's disease fistula
| [0184]
|
| Fistulizing Crohn's disease: Diagnosis and management
| [0184]
|
| Mesenchymal stem cells: mechanisms of inflammation
| [0184]
|
| Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases
| [0184]
|
| Recurrent anal fistulae: limited surgery supported by stem cells
| [0184]
|
| Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial
| [0184]
|
| Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
| [0184]
|
| Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group
| [0184]
|
| A new measure of health status for clinical trials in inflammatory bowel disease
| [0184]
|
| Adalimumab for the treatment of fistulas in patients with Crohn's disease
| [0184]
|
| A sharper Bonferroni procedure for multiple tests of significance
| [0184]
|
| The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
| [0184]
|
| Review article: The medical treatment of Crohn's perianal fistulas
| [0184]
|
| American Gastroenterological Association medical position statement: perianal Crohn's disease
| [0184]
|
| Recent developments in the surgical management of perianal fistula for Crohn's disease
| [0184]
|